FLUOXETINE TEVA 20 mg, hard capsule 14 capsules
Active ingredients: Fluoxetine hydrochloride, Fluoxetine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule14 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- FLUOXETINE TEVA 20 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium PVDC de 14 gélule(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jul 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60681934CIP73611804CIP133400936118041Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE FLUOXÉTINEgélule | 22,36 mg · une gélule | SA |
| FLUOXÉTINE BASEgélule | 20 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.